Biosynex S.A.
ALBIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 8.8% | -52.7% | -48.6% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | -19.8% | 52.8% | 32.8% | 47.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | €0 | €0 |
| % Margin | -20.8% | -40.2% | 19.8% | 36.8% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | -€0 |
| Pre-Tax Income | -€0 | -€0 | €0 | €0 |
| Tax Expense | -€0 | -€0 | €0 | €0 |
| Net Income | -€0 | -€0 | €0 | €0 |
| % Margin | -42.8% | -39.7% | 8% | 27.2% |
| EPS | -3.32 | -2.85 | 1.26 | 8.32 |
| % Growth | -16.5% | -326.2% | -84.9% | – |
| EPS Diluted | -3.32 | -2.85 | 1.26 | 8.27 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | €0 | €0 |
| % Margin | -17.6% | -11% | 23.8% | 38.3% |